Back to search

Article

A nationwide study of 331 rare diseases among 58 million individuals: prevalence, demographics, and COVID-19 outcomes

2023-10-13

Abstract excerpt

<h4>Background</h4> The Global Burden of Disease study has provided key evidence to inform clinicians, researchers, and policy makers across common diseases, but no similar effort with single study design exists for hundreds of rare diseases. Consequently, many rare conditions lack population-level evidence including prevalence and clinical vulnerability. This has led to the absence of evidence-based care for rare...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
723e8d2a-eea8-50df-a0c7-bdc5d59d55f5
DOI
10.1101/2023.10.12.23296948
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A nationwide study of 331 rare diseases among 58 million individuals: prevalence, demographics, and COVID-19 outcomesDOI 10.1101/2023.10.12.23296948
The Orphanet Nomenclature of rare diseases: a standard terminology for improved patient recognition and data interoperabilitySemantic proximity
Time to diagnosis and determinants of diagnosis delays of people living with a rare disease: a Rare Barometer retrospective patient surveySemantic proximity
Spectrum and epidemiology of rare diseases in a Chinese natural population of 14.31 million residents, 2012–2023Semantic proximity
Complex patterns of multimorbidity associated with severe COVID-19 and Long COVIDSemantic proximity
Prevalence of 406 rare diseases by ethnicity and their associated COVID-19 infection burden: A national cross-sectional study of 62.5 million people in EnglandSemantic proximity
A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19Semantic proximity
Systematic identification of rare disease patients in electronic health records enables evaluation of clinical outcomesSemantic proximity
Medical Risk Classification For Severe COVID-19 Based On Chronic Medical Conditions: A Comparative AnalysisSemantic proximity
Rare diseases in Tanzania: a National Call for Action to address policy and urgent needs of individuals with rare diseasesSemantic proximity
Shortcutting the diagnostic odyssey: the multidisciplinary Program for Undiagnosed Rare Diseases in adults (UD-PrOZA)Semantic proximity
Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patientsSemantic proximity
Clinical and Epidemiological Data of COVID-19 from Regensburg, Germany – A Retrospective analysis of 1084 consecutive casesSemantic proximity
Select a neighboring publication to make it the new centre.